Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the ...

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...

Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer’s drug that effectively prevents the build-up of Tau proteins -- a key driver ...

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...